nach oben

European Journal of Trauma and Emergency Surgery

Erschienen in:

16.09.2017 | Review Article

Fibrinolysis in trauma: a review

verfasst von: M. J. Madurska, K. A. Sachse, J. O. Jansen, T. E. Rasmussen, J. J. Morrison

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Fibrinolytic dysregulation is an important mechanism in traumatic coagulopathy. It is an incompletely understood process that consists of a spectrum ranging from excessive breakdown (hyperfibrinolysis) and the shutdown of fibrinolysis. Both hyperfibrinolysis and shutdown are associated with excess mortality and post-traumatic organ failure. The pathophysiology appears to relate to endothelial injury and hypoperfusion, with several molecular markers identified in playing a role. Although there are no universally accepted diagnostic tests, viscoelastic studies appear to offer the greatest potential for timely identification of patients presenting with fibrinolytic dysregulation. Treatment is multimodal, involving prompt hemorrhage control and resuscitation, with controversy surrounding the use of antifibrinolytic drug therapy. This review presents the current evidence on the pathophysiology, diagnostic challenges, as well as the management of this hemostatic dysfunction.

Level of evidence: Level III.

Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127–30. doi:10.1097/01.TA.0000069184.82147.06.CrossRefPubMed

Tauber H, Innerhofer P, Breitkopf R, Westermann I, Beer R, El Attal R, Strasak A, Mittermayr M. Prevalence and impact of abnormal ROTEM assays in severe blunt trauma: results of the “diagnosis and treatment of trauma-induced coagulopathy (DIA-TRE-TIC) study. Br J Anaesth. 2011;107(3):378–87. doi:10.1093/bja/aer158.CrossRefPubMed

Moore HB, Moore EE, Gonzalez E, Chapman MP, Chin TL, Silliman CC, Banerjee A, Sauaia A. Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy. J Trauma Acute Care Surg. 2014;77(6):811–7. doi:10.1097/TA.0000000000000341. (discussion 817).CrossRefPubMedPubMedCentral

Hoffman M, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21(1):1–11. doi:10.1016/j.hoc.2006.11.004.CrossRefPubMed

Bajzar L, Nesheim ME, Tracy PB. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood. 1996;88(6):2093–100.PubMed

Ferreira CN, Sousa MDO. A cell-based model of coagulation and its implications. Rev Bras Hematol e Hemoter. 2010;32(5):416–21. doi:10.1590/S1516-84842010000500016.CrossRef

Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16(1/2):17–20. doi:10.1023/B:THRO.0000014588.95061.28.CrossRefPubMed

Jakubowski HV, Owen WG. Macromolecular specificity determinants on thrombin for fibrinogen and thrombomodulin. J Biol Chem. 1989;264(19):11117–21.PubMed

Moore H, Moore E, Gonzalez E. Fibrinolysis. In: Gonzalez E, Moore H, Moore E, editors. Trauma induced coagulopathy. 1st ed. Cham: Springer International Publishing; 2016. pp. 135–47. doi:10.1007/978-3-319-28308-1_9.CrossRef

10.

Cotton B, Harvin J, Kostousouv V, Minei KM, Radwan Z, Schöchl H, Wade CE, Holcomb JB, Matijevic N. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73(2):365–70. doi:10.1097/TA.0b013e31825c1234.CrossRefPubMed

11.

Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, Pittet JF. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211–7. doi:10.1097/TA.0b013e318169cd3c. 1217.CrossRefPubMed

12.

Kashuk JL, Moore EE, Sawyer M, Wohlauer M, Pezold M, Barnett C, Biffl WL, Burlew CC, Johnson JL, Sauaia A. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252(3):434. doi:10.1097/SLA.0b013e3181f09191.PubMed

13.

Brohi K, Cohen MJ, Ganter MT, Matthay M a, Mackersie RC, Pittet J-F. Acute traumatic coagulopathy: initiated by hypoperfusion, modulated through the protein C pathway? Ann Surg. 2007;245(5):812–8. doi:10.1097/01.sla.0000256862.79374.31.CrossRefPubMedPubMedCentral

14.

Williams-Johnson JA, McDonald AH, Strachan GG, Williams EW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) a randomised, placebo-controlled trial. The Lancet. 2010;376(6):612–24. doi:10.1016/S0140-6736(10)60835-5.

15.

Rezaie AR. Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1: implications for the mechanism of profibrinolytic action of activated protein C. J Biol Chem. 2001;276(19):15567–70. doi:10.1074/jbc.C100123200.CrossRefPubMed

16.

Davenport RA, Guerreiro M, Frith D, Rourke C, Platton S, Cohen M, Pearse R, Thiemermann C, Brohi C. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy. Anesthesiology. 2017;126(1):115–27. doi:10.1097/ALN.0000000000001428.CrossRefPubMedPubMedCentral

17.

Solomon C, Traintinger S, Ziegler B, Hanke A, Rahe-Meyer N, Voelckel W, Schöchl H. Platelet function following trauma. A multiple electrode aggregometry study. Thromb Haemost. 2011;106(2):322–30. doi:10.1160/TH11-03-0175.CrossRefPubMed

18.

Ostrowski SR, Henriksen HH, Stensballe J, Gybel-Brask M, Cardenas JC, Baer LA, Cotton BA, Holcomb JB, Wade CE, Johansson PI. Sympathoadrenal activation and endotheliopathy are drivers of hypocoagulability and hyperfibrinolysis in trauma: a prospective observational study of 404 severely injured patients. J Trauma Acute Care Surg. 2017. doi:10.1097/TA.0000000000001304.PubMed

19.

Chakrabarti R, Hocking E, Fearnley G. Reaction pattern to three stresses—electroplexy, surgery, and myocardial infarction—of fibrinolysis and plasma fibrinogen. J Clin Pathol. 1969;22(6):659–62.CrossRefPubMedPubMedCentral

20.

Moore HB, Moore EE, Liras IN, Gonzalez E, Harvin JA, Holcomb JB, Sauaia A, Cotton BA. Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2540 severely injured patients. J Am Coll Surg. 2016;222(4):347–55. doi:10.1016/j.jamcollsurg.2016.01.006.CrossRefPubMedPubMedCentral

21.

Leeper C, Neal M, McKenna C, Sperry J, Gaines B. Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population. J Trauma Acute Care Surg. 2017;82(1):27–34.CrossRefPubMed

22.

Moore HB, Moore EE, Lawson P, Gonzalez E, Fragoso M, Morton AP, Goboni F, Chapman MP, Sauaia A, Baneree A, et al. Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock. Surgery. 2015;158(2):386–92. doi:10.4315/0362-028X.JFP-13-395.Knowledge.CrossRefPubMedPubMedCentral

23.

Macko A, Moore H, Cap A, Meledeo M, Moore E, Sheppard F. Tissue injury suppresses fibrinolysis after hemorrhagic shock in nonhuman primates (rhesus macaque). J Trauma Acute Care Surg. 2017;82(4):750–7. doi:10.1097/TA.0000000000001379.CrossRefPubMedPubMedCentral

24.

Hoffman M, Monroe DMI. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958–65.PubMed

25.

Kowalski O, Kopec M, Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J Clin Pathol. 1959;215(12):215–8.CrossRef

26.

Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res. 2004;112(5–6):329–37. doi:10.1016/j.thromres.2004.01.001.

27.

Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth. 2008;100(6):792–7. doi:10.1093/bja/aen083.CrossRefPubMed

28.

Theusinger OM, Wanner G a, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen HP, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg. 2011;113(5):1003–12. doi:10.1213/ANE.0b013e31822e183f.CrossRefPubMed

29.

Johansson PI, Sørensen AM, Perner A, Welling KL, Wanscher M, Larsen CF. Ostrowski SR disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. Crit Care. 2011;15(6):R272. doi:10.1186/cc10553.CrossRefPubMedPubMedCentral

30.

Johansson PI, Stissing T, Bochsen L, Ostrowski SR. Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med. 2009;17:1–8. doi:10.1186/1757-7241-17-45.CrossRef

31.

Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14(2):R55. doi:10.1186/cc8948.CrossRefPubMedPubMedCentral

32.

Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27(2):81–90. doi:10.1111/j.1365-2257.2005.00681.x.CrossRefPubMed

33.

Carroll RC, Craft RM, Langdon RJ, Clanton CR, Snider CC, Wellons DD, Dakin PA, Lawson CM, Enderson BL, Kurek SJ. Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl Res. 2009;154(1):34–9. doi:10.1016/j.trsl.2009.04.001.CrossRefPubMed

34.

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand. 2010;54(1):111–7. doi:10.1111/j.1399-6576.2009.02132.x.CrossRefPubMed

35.

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S. Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. Br J Anaesth. 2012;109(3):376–81. doi:10.1093/bja/aes186.CrossRefPubMed

36.

Schöchl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011;15(2):R83. doi:10.1186/cc10078.CrossRefPubMedPubMedCentral

37.

Afshari A, Wikkelsø A, Brok J, Am M, Wetterslev J, Afshari A, Wikkelsø A, Brok J, Møller AM, Wetterslev J. TEG or ROTEM to monitor haemotherapy versus usual care in patients with massive transfusion (review). Cochrane Database Syst Rev. 2013. doi:10.1002/14651858.CD007871.pub2.Copyright.PubMed

38.

Genét GF, Ostrowski SR, Sørensen AM, Johansson PI. Detection of tPA-induced hyperfibrinolysis in whole blood by RapidTEG, KaolinTEG, and functional fibrinogenTEG in healthy individuals. Clin Appl Thromb Hemost. 2012;18(6):638–44. doi:10.1177/1076029611434527.CrossRefPubMed

39.

Moore H, Moore E, Chapman M, Huebner BR, Einersen PM, Oushy S, Silliman CC, Banerjee A, Sauaia A. Viscoelastic tissue plasminogen activator challenge predicts massive transfusion in 15 min. J Am Coll Surg. 2017;225(1):138–47.CrossRefPubMed

40.

Ives C, Inaba K, Branco BC, Okoye O, Schochl H, Talving P, Lam L, Shulman I, Nelson J, Demetriades D. Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma. J Am Coll Surg. 2012;215(4):496–502. doi:10.1016/j.jamcollsurg.2012.06.005.CrossRefPubMed

41.

Schöchl H, Frietsch T, Pavelka M, Jámbor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67(1):125–31. doi:10.1097/TA.0b013e31818b2483.CrossRefPubMed

42.

Davenport R, Manson J, De’Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med. 2011;39(12):2652–8. doi:10.1097/CCM.0b013e3182281af5.CrossRefPubMedPubMedCentral

43.

Lang T, Bauters A, Braun SL, Po B. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis. 2005;16(6):301–10.CrossRefPubMed

44.

Sharma R, Letson HL, Smith S, Dobson GP. Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study. J Surg Res. 2016;7:1–13. doi:10.1016/j.jss.2017.05.006.CrossRef

45.

Kutcher ME, Cripps MW, McCreery RC, Crane IM, Greenberg MD, Cachola LM, Redick BJ, Nelson MF, Cohen MJ. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012;73(1):87–93. doi:10.1097/TA.0b013e3182598c70.CrossRefPubMedPubMedCentral

46.

Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma. J Trauma Acute Care Surg. 2013;74(6):1575–86. doi:10.1097/TA.0b013e318292cc54.CrossRefPubMed

47.

Morrison JJ, Ross JD. Is viscoelastic evidence of hyperfibrinolysis the ideal indicator for tranexamic acid administration in trauma? Letters to the editor. J Trauma Acute Care Surg. 2013;33(3):436–7.

48.

Olldashi F, Kerçi M, Zhurda T, Ruçi K, Banushi A, Traverso MS, Jiménez J, Balbi J, Dellera C, Svampa S. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. The Lancet. 2011;377(9771):1096–101. doi:10.1016/S0140-6736(11)60278-X. (1101.e1–1101.e2).CrossRef

49.

Lin GG, Scott JG. The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal. J Thromb Haemost. 2013;11(7):130–4. doi:10.1016/j.pestbp.2011.02.012.Investigations.

50.

Leeper CM, Neal MD, McKenna CJ, Gaines BA. Trending fibrinolytic dysregulation. Ann Surg. 2017;266(3):505–15. doi:10.1097/SLA.0000000000002355.CrossRef

51.

Nagler M, ten Cate H, Kathriner S, Casutt M, Bachmann LM, Wuillemin WA. Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers. Thromb Haemost. 2014;111(6):1161–6. doi:10.1160/TH13-10-0870.CrossRefPubMed

52.

Scarpelini S, Rhind SG, Nascimento B, Tien H, Shek PN, Peng HT, Huang H, Pinto R, Speers V, Reis M. Normal range values for thromboelastography in healthy adult volunteers. Braz J Med Biol Res. 2009;42(12):1210–7.CrossRefPubMed

53.

Gall L, Brohi K, Davenport R. Diagnosis and treatment of hyperfibrinolysis in trauma (a European perspective). Semin Thromb Hemost. 2017;43(2):224–34. doi:10.1055/s-0036-1598001.CrossRefPubMed

54.

TEG ® 5000 Thrombelastograph ® Hemostasis System User Manual. Haemoscope Corporation. 2008. http://www.haemonetics.com/en/products/devices/surgical-and-diagnostic-devices/teg-5000. Accessed 1 Sep 2017.

55.

Ostrowski SR, Sørensen AM, Larsen CF, Johansson PI. Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. Scand J Trauma Resusc Emerg Med. 2011;19(1):64. doi:10.1186/1757-7241-19-64.CrossRefPubMedPubMedCentral

56.

Raza I, Davenport R, Rourke C, Platton S, Manson J, Spoors C, Khan S, De’Ath HD, Allard S, Hart DP. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11(2):307–14. doi:10.1111/jth.12078.CrossRefPubMed

57.

Theusinger OM, Wanner GA, Emmert MY, Billeter A, Eismon J, Seifert B, Simmen H-P, Spahn DR, Baulig W. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg. 2011;113(5):1003–12. doi:10.1213/ANE.0b013e31822e183f.CrossRefPubMed

58.

Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth. 2008;101:769–73. doi:10.1093/bja/aen270.CrossRefPubMed

59.

Nienaber U, Innerhofer P, Westermann I, Schochl H, Attal R, Breitkopf R, Maegele M. The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. Injury. 2011;42(7):697–701. doi:10.1016/j.injury.2010.12.015.CrossRefPubMed

60.

Huebner BR, Moore EE, Moore HB, Sauaia A, Stettler G, Dzieciatkowska M, Hansen K. Freeze-dried plasma enhances clot formation and inhibits fibrinolysis in the presence of tissue plasminogen activator similar to pooled liquid plasma. Transfusion. doi:10.1111/trf.14149.

61.

Kostousov V, Wang Y-WW, Cotton BA, Wade CE, Holcomb JB, Matijevic N. Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model. Blood Coagul Fibrinolysis. 2013;24(5):489–97. doi:10.1097/MBC.0b013e32835e4246.CrossRefPubMed

62.

Morton A, Moore E, Moore H, Gonzalez E, Chapman MP, Peltz E, Banerjee A, Silliman C. Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin. J Surg Res. 2017;213:166–70. doi:10.1016/j.jss.2015.04.077.CrossRefPubMed

63.

Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113–9. doi:10.1001/archsurg.2011.287.CrossRefPubMed

64.

Cole E, Davenport R, Willett K, Brohi K. Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study. Ann Surg. 2015;261(2):390–4. doi:10.1097/SLA.0000000000000717.CrossRefPubMed

65.

Louro J, Andersen K, Dudaryk R. Correction of severe coagulopathy and hyperfibrinolysis by tranexamic acid and recombinant factor VIIa in a cirrhotic patient after trauma: a case report. A A Case Rep. 2017;9(5):144–7. doi:10.1213/XAA.0000000000000550.CrossRefPubMed

66.

Swendsen H, Galante JM, Utter GH, Bateni S, Scherer LA, Schermer CR. Tranexamic acid use in trauma: effective but not without consequences. Trauma Treat. 2013. doi:10.4172/2167-1222.1000179.

67.

Pabinger I, Fries D, Schöchl H, Streif W, Toller W. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. 2017;129(9–10):303–16. doi:10.1007/s00508-017-1194-y.CrossRefPubMedPubMedCentral

68.

Walsh M, Shreve J, Thomas S, Moore E, Moore H, Hake D, Pohlman T, Davis P, Ploplis V, Piscoya A, et al. Fibrinolysis in Trauma: “myth,” “reality,” or “something in between”. Semin Thromb Hemost. 2017;43(2):200–12. doi:10.1055/s-0036-1597900.CrossRefPubMed

69.

Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl. 1987;137:22–5.CrossRefPubMed

70.

Roberts I, Shakur H, Ker K, Coats T. Antifibrinolytic drugs for acute traumatic injury (review). Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.CD004896.pub4.Copyright.PubMedCentral

71.

Zickenrott V, Greb I, Henkelmann A, Balzer F, Casu S, Kaufne L, von Heymann C, Zacharowski K, Weber CF. Tranexamic acid in the German emergency medical service: a national survey. Anaesthesist. 2017;66(4):249–55. doi:10.1007/s00101-017-0277-5.CrossRefPubMed

72.

Huebner BR, Dorlac WC, Cribari C. Tranexamic acid use in prehospital uncontrolled hemorrhage. Wilderness Environ Med. 2017;28(2S):S50–S60. doi:10.1016/j.wem.2016.12.006.CrossRefPubMedPubMedCentral

73.

Roberts I, Prieto-Merino D, Manno D. Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial. Crit Care. 2014;18(6):685. doi:10.1186/s13054-014-0685-8.CrossRefPubMedPubMedCentral

74.

Roberts I. Tranexamic acid in trauma: how should we use it? J Thromb Haemost. 2015;13(Supple1):S195–9. doi:10.1111/jth.12878.CrossRefPubMed

75.

Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt B, Lecky F, Brohi K, Willett K. CRASH-2 collaborators. Effect of tranexamic acid on mortlity in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. Bmj. 2012;345:e5839. doi:10.1136/bmj.e5839.CrossRefPubMedPubMedCentral

76.

MacLaren R, Stringer K. Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome. Pharmacotherapy. 2007;27(6):860–73.CrossRefPubMedPubMedCentral

77.

Hardaway R, Harkey H, Tyroch A, WIlliams C, Vazquez Y, Krause G. Treatment of severe acute respiratory distress syndrome: a final report on a phase I study. Am Surg. 2001;67(4):377–82.PubMed

78.

ClinicalTrials.gov—a service of the US National Institutes of Health. https://clinicaltrials.gov. Accessed 4 Sep 2017.

79.

Kalavrouziotis D, Voisine P, Mohammadi S, Dionne S, Dagenais F. High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass. Ann Thorac Surg. 2012;93(1):148–54. doi:10.1016/j.athoracsur.2011.07.085.CrossRefPubMed

80.

Hunter GRW, Young GB. Seizures after cardiac surgery. J Cardiothorac Vasc Anesth. 2011;25(2):299–305. doi:10.1053/j.jvca.2010.08.004.CrossRefPubMed

81.

Dewan Y, O Komolafe E, Mejia-Mantilla J, Perel P, Roberts I, Shakur H. CRASH-3—tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial. Trials. 2012. doi:10.1186/1745-6215-13-87.PubMedPubMedCentral

82.

PATCH—trauma study. The pre-hospital anti-fibrinolytics for traumatic coagulopathy and haemorrhage study. https://www.patchtrauma.org. Accessed 4 September 2017.

Titel: Fibrinolysis in trauma: a review
verfasst von: M. J. Madurska
K. A. Sachse
J. O. Jansen
T. E. Rasmussen
J. J. Morrison
Publikationsdatum: 16.09.2017
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Trauma and Emergency Surgery / Ausgabe 1/2018
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-017-0833-3

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

16.04.2024 | Spondylitis ankylosans | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Fibrinolysis in trauma: a review

Abstract

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

The effects of Hurricane Sandy on trauma center admissions

Correction to: Traumatic inferior shoulder dislocation: a review of management and outcome

Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept

Two-stage treatment in patients with patients with high-energy femoral fractures does not lead to an increase in deep infectious complications: a propensity score analysis

Predictors of outcome in 101 patients requiring emergent thoracotomy for penetrating pulmonary injuries

End cap versus no end cap in intramedullary nailing for displaced midshaft clavicle fractures: influence on implant-related irritation

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Zwei neue Alternativen zu TNF-Inhibitoren bei axSpA

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

Update Orthopädie und Unfallchirurgie